Anemia in Children: Clinical Case and Viva QnA

Document
Clinical Case of Anemia in Children

A 4-year-old boy is brought to the pediatric clinic by his mother with complaints of fatigue, irritability, and decreased appetite for the past month. The mother reports that her son has become increasingly pale and seems to tire easily during play. History: - No significant past medical history - Up-to-date on vaccinations - No recent illnesses or injuries - Diet consists mainly of milk, bread, and pasta - No history of blood in stools or urine Physical Examination: - Weight: 15 kg (10th percentile) - Height: 100 cm (25th percentile) - Pale conjunctiva and nail beds - Mild tachycardia (heart rate 110 bpm) - No hepatosplenomegaly - No signs of bruising or petechiae Laboratory Results: - Hemoglobin: 8.5 g/dL (normal range for age: 11.5-13.5 g/dL) - Mean Corpuscular Volume (MCV): 70 fL (normal range for age: 75-87 fL) - Serum ferritin: 8 ng/mL (normal range: 12-140 ng/mL) - Peripheral blood smear: Microcytic, hypochromic red blood cells Diagnosis: Iron deficiency anemia Management: 1. Oral iron supplementation: 3-6 mg/kg/day of elemental iron for 3 months 2. Dietary counseling to increase iron-rich foods 3. Follow-up in 4 weeks to reassess hemoglobin levels and clinical symptoms 4. Education on iron absorption enhancers (vitamin C) and inhibitors (calcium, tea) 5. Investigation of potential causes of iron deficiency (e.g., occult blood loss, malabsorption)

Clinical Presentations of Anemia in Children
  1. Iron Deficiency Anemia:
    • Pallor of skin, mucous membranes, and nail beds
    • Fatigue and decreased energy levels
    • Irritability and poor concentration
    • Pica (craving for non-food items like ice or dirt)
    • Koilonychia (spoon-shaped nails)
  2. Thalassemia:
    • Pallor and jaundice
    • Hepatosplenomegaly
    • Growth retardation
    • Skeletal changes (frontal bossing, maxillary hypertrophy)
    • Leg ulcers (in older children with thalassemia major)
  3. Sickle Cell Anemia:
    • Recurrent pain crises
    • Acute chest syndrome
    • Splenic sequestration
    • Increased susceptibility to infections
    • Delayed growth and sexual maturation
  4. Aplastic Anemia:
    • Severe pallor
    • Fatigue and weakness
    • Petechiae and easy bruising
    • Recurrent infections
    • Bleeding from mucous membranes
  5. Vitamin B12 Deficiency Anemia:
    • Pallor and fatigue
    • Glossitis (inflammation of the tongue)
    • Developmental delays or regression
    • Neurological symptoms (paresthesias, ataxia)
    • Irritability and behavioral changes
  6. Hemolytic Anemia:
    • Sudden onset of pallor and fatigue
    • Jaundice and dark urine
    • Abdominal pain and splenomegaly
    • Tachycardia and dyspnea
    • Fever (in some cases)
  7. Lead Poisoning Anemia:
    • Abdominal pain and constipation
    • Irritability and behavioral changes
    • Developmental delays or regression
    • Basophilic stippling of red blood cells on peripheral smear
    • Anemia with or without obvious pallor
Viva Questions and Answers on Anemia in Children
  1. Q: What is the most common cause of anemia in children worldwide?

    A: Iron deficiency is the most common cause of anemia in children worldwide. It accounts for approximately 50% of all cases of anemia in children.

  2. Q: How does the normal hemoglobin level vary with age in children?

    A: Hemoglobin levels vary significantly with age: - Newborn: 14-24 g/dL - 2-6 months: 9.5-13.5 g/dL - 6 months-2 years: 10.5-13.5 g/dL - 2-12 years: 11.5-13.5 g/dL - 12-18 years (female): 12-16 g/dL - 12-18 years (male): 13-16 g/dL

  3. Q: What are the main causes of microcytic anemia in children?

    A: The main causes of microcytic anemia in children are: 1. Iron deficiency anemia 2. Thalassemia 3. Anemia of chronic disease 4. Sideroblastic anemia 5. Lead poisoning

  4. Q: How do you differentiate between iron deficiency anemia and thalassemia minor based on red cell indices?

    A: The Mentzer index (MCV/RBC count) is useful: - If Mentzer index < 13: suspect thalassemia minor - If Mentzer index > 13: suspect iron deficiency anemia Additionally, RDW is typically elevated in iron deficiency but normal in thalassemia minor.

  5. Q: What is the recommended daily iron intake for infants and toddlers?

    A: Recommended daily iron intake: - 0-6 months: 0.27 mg/day (from breast milk or formula) - 7-12 months: 11 mg/day - 1-3 years: 7 mg/day

  6. Q: What are the neurological manifestations of vitamin B12 deficiency in infants?

    A: Neurological manifestations of vitamin B12 deficiency in infants include: - Developmental delay or regression - Hypotonia - Seizures - Movement disorders (tremors, myoclonus) - Failure to thrive - Irritability and apathy

  7. Q: How does sickle cell disease present in infancy?

    A: Sickle cell disease often presents in infancy with: - Dactylitis (painful swelling of hands and feet) - Pallor and jaundice - Splenomegaly - Increased susceptibility to infections, especially pneumococcal sepsis - Anemia (may not be severe initially due to persistence of fetal hemoglobin)

  8. Q: What is the role of hepcidin in iron deficiency anemia?

    A: Hepcidin is a key regulator of iron homeostasis: - It inhibits iron absorption from the gut and iron release from macrophages - In iron deficiency, hepcidin levels are suppressed, allowing increased iron absorption and mobilization - In anemia of chronic disease, hepcidin levels are elevated, contributing to iron-restricted erythropoiesis

  9. Q: How do you manage iron deficiency anemia in a child with inflammatory bowel disease?

    A: Management includes: 1. Treat underlying IBD to reduce inflammation 2. Iron supplementation (oral if tolerated, IV if oral not tolerated or ineffective) 3. Monitor for response with hemoglobin and ferritin levels 4. Consider erythropoiesis-stimulating agents if anemia persists despite adequate iron stores 5. Nutritional support and counseling

  10. Q: What are the indications for blood transfusion in a child with thalassemia major?

    A: Indications for blood transfusion in thalassemia major: - To maintain pre-transfusion hemoglobin > 9-10.5 g/dL - Symptomatic anemia (e.g., poor growth, exercise intolerance) - Complications of anemia (e.g., heart failure) - Before major surgery - During pregnancy

  11. Q: How does alpha-thalassemia differ from beta-thalassemia in terms of genetic inheritance and clinical presentation?

    A: Alpha-thalassemia: - Involves 4 genes (2 on each chromosome 16) - Silent carrier (1 gene affected) to hydrops fetalis (all 4 genes affected) - HbH disease (3 genes affected) can present with hemolytic anemia and splenomegaly Beta-thalassemia: - Involves 2 genes (1 on each chromosome 11) - Beta-thalassemia minor (1 gene affected) to beta-thalassemia major (both genes affected) - Beta-thalassemia major presents with severe anemia, growth retardation, and skeletal changes

  12. Q: What is the approach to diagnosing the cause of anemia in a child?

    A: Diagnostic approach: 1. Complete blood count with reticulocyte count 2. Peripheral blood smear 3. Iron studies (serum iron, TIBC, ferritin) 4. Based on initial results: - If microcytic: consider iron studies, hemoglobin electrophoresis - If normocytic: consider hemolysis workup, bone marrow evaluation - If macrocytic: consider vitamin B12 and folate levels 5. Additional tests based on clinical suspicion (e.g., lead levels, G6PD assay)

  13. Q: How does anemia affect growth and development in children?

    A: Anemia can impact growth and development through: - Reduced oxygen delivery to tissues, leading to fatigue and decreased physical activity - Impaired cognitive function and school performance - Altered appetite and nutrient absorption - In severe cases, cardiac complications affecting overall health - Iron deficiency (even without anemia) can affect neurocognitive development

  14. Q: What are the potential complications of chronic transfusion therapy in children?

    A: Complications of chronic transfusion therapy include: 1. Iron overload (hemosiderosis) 2. Alloimmunization 3. Transfusion reactions (acute and delayed) 4. Transmission of infectious diseases (rare with modern screening) 5. Fluid overload 6. Hypersplenism 7. Psychosocial impact of frequent hospital visits

  15. Q: How do you manage aplastic anemia in a child?

    A: Management of aplastic anemia involves: 1. Supportive care (transfusions, infection prophylaxis) 2. Immunosuppressive therapy (ATG + cyclosporine) for non-severe cases or if no matched donor 3. Hematopoietic stem cell transplantation for severe cases with a matched donor 4. Growth factors (e.g., G-CSF) in selected cases 5. Regular monitoring for response and complications 6. Psychosocial support for the child and family

  16. Q: What is the role of erythropoiesis-stimulating agents (ESAs) in pediatric anemia?

    A: ESAs in pediatric anemia: - Used in anemia of chronic kidney disease - May be considered in chemotherapy-induced anemia - Can be used in selected cases of anemia of prematurity - Not routinely used in iron deficiency anemia or other nutritional anemias - Potential risks include hypertension and thrombotic events, requiring careful monitoring

  17. Q: How does hemolytic disease of the newborn (HDN) present, and what are its long-term consequences?

    A: HDN presentation: - Jaundice within 24 hours of birth - Pallor, hepatosplenomegaly - Hydrops fetalis in severe cases Long-term consequences: - Kernicterus (bilirubin encephalopathy) if severe jaundice untreated - Developmental delays - Hearing loss - Movement disorders Early recognition and treatment (phototherapy, exchange transfusion) can prevent long-term sequelae.

  18. Q: What are the indications for iron supplementation in premature infants?

    A: Indications for iron supplementation in premature infants: - All preterm infants < 32 weeks gestation or birth weight < 1500g - Start when feeding volumes reach 100 mL/kg/day or at 2 weeks of age, whichever comes first - Dose: 2-3 mg/kg/day of elemental iron - Continue until 12 months of age or longer if still on predominant breast milk diet - Monitor for iron deficiency and adjust dose based on lab results and growth

  19. Q: How does G6PD deficiency present in children, and what are the management principles?

    A: G6PD deficiency presentation: - Acute hemolytic anemia triggered by oxidative stress (certain drugs, foods, infections) - Neonatal jaundice - Chronic hemolysis (rare) Management principles: 1. Avoid known triggers (e.g., fava beans, certain antibiotics) 2. Prompt treatment of infections 3. Education of parents and child about the condition 4. Supportive care during hemolytic episodes (hydration, folic acid supplementation) 5. Transfusion if severe anemia or symptomatic 6. Screening family members

  20. Q: What is Diamond-Blackfan anemia, and how is it managed?

    A: Diamond-Blackfan anemia: - Congenital pure red cell aplasia - Presents in infancy with severe macrocytic anemia - Associated with physical anomalies in ~50% of cases Management: 1. Corticosteroids (first-line treatment) 2. Regular transfusions if steroid-refractory 3. Hematopoietic stem cell transplantation for transfusion-dependent cases 4. Iron chelation for transfusion-related iron overload 5. Genetic counseling for families

  21. Q: How do you approach a child with pancytopenia?

    A: Approach to pancytopenia: 1. Confirm true pancytopenia with repeat CBC and peripheral smear 2. Detailed history and physical examination 3. Initial investigations: - Reticulocyte count - Vitamin B12 and folate levels - Viral studies (EBV, CMV, HIV, Parvovirus B19) - Autoimmune workup (ANA, RF) 4. Bone marrow aspiration and biopsy 5. Consider specialized tests based on suspicion: - Genetic testing for inherited bone marrow failure syndromes - Flow cytometry for PNH - Chromosomal breakage studies for Fanconi anemia 6. Manage underlying cause and provide supportive care

  22. Q: What are the hematological manifestations of systemic lupus erythematosus (SLE) in children?

    A: Hematological manifestations of SLE in children: 1. Anemia: - Anemia of chronic disease - Autoimmune hemolytic anemia - Iron deficiency anemia 2. Leukopenia (particularly lymphopenia) 3. Thrombocytopenia 4. Antiphospholipid syndrome (thrombosis, recurrent miscarriages) 5. Thrombotic thrombocytopenic purpura (rare) 6. Macrophage activation syndrome (rare but life-threatening)

  23. Q: How does lead poisoning cause anemia, and what are the key diagnostic features?

    A: Lead poisoning and anemia: - Lead inhibits several enzymes in the heme biosynthesis pathway - Causes both decreased red cell production and increased hemolysis Key diagnostic features: 1. Microcytic, hypochromic anemia 2. Basophilic stippling of red cells on peripheral smear 3. Elevated free erythrocyte protoporphyrin (FEP) or zinc protoporphyrin (ZPP) 4. Elevated blood lead levels (BLL) 5. Associated symptoms: abdominal pain, constipation, developmental delays, behavioral changes Diagnosis confirmed by BLL > 5 µg/dL, treatment usually initiated at BLL > 45 µg/dL

  24. Q: What is the role of nutrition in preventing and treating anemia in children?

    A: Role of nutrition: 1. Iron-rich foods: red meat, fortified cereals, leafy greens 2. Vitamin C to enhance iron absorption 3. Vitamin B12 sources: animal products, fortified foods 4. Folate sources: leafy greens, legumes, fortified foods 5. Avoiding excessive milk intake in toddlers (can lead to iron deficiency) 6. Education on balanced diet and appropriate complementary feeding 7. In developing countries, consideration of food fortification programs 8. Addressing malnutrition and micronutrient deficiencies holistically

  25. Q: How do you manage anemia in a child with inflammatory bowel disease (IBD)?

    A: Management of anemia in IBD: 1. Treat underlying IBD to reduce inflammation 2. Iron supplementation: - Oral iron if mild anemia and quiescent disease - IV iron if moderate-severe anemia, active disease, or intolerance to oral iron 3. Monitor response with hemoglobin, ferritin, and transferrin saturation 4. Consider erythropoiesis-stimulating agents if anemia persists despite adequate iron stores 5. Evaluate and treat other nutrient deficiencies (B12, folate) 6. Regular screening for anemia in all IBD patients 7. Nutritional support and counseling

  26. Q: What are the indications for splenectomy in children with hemolytic anemias, and what precautions are necessary?

    A: Indications for splenectomy: 1. Hereditary spherocytosis with severe anemia or recurrent crises 2. Refractory immune thrombocytopenia (ITP) 3. Symptomatic hypersplenism in thalassemia major Precautions: 1. Delay until > 5 years old if possible (ideally > 10 years) 2. Vaccinations: pneumococcal, Haemophilus influenzae type b, meningococcal (at least 2 weeks before surgery) 3. Antibiotic prophylaxis post-splenectomy (usually until 18 years old) 4. Education about risk of overwhelming post-splenectomy infection (OPSI) 5. Prompt treatment of febrile illnesses 6. Consider partial splenectomy in young children

  27. Q: How does anemia affect cardiopulmonary function in children, and what are the implications for management?

    A: Effects on cardiopulmonary function: 1. Increased cardiac output to maintain tissue oxygenation 2. Tachycardia and flow murmurs 3. In severe cases, high-output cardiac failure 4. Decreased exercise tolerance and dyspnea on exertion Implications for management: 1. Regular cardiac evaluation in chronic anemias 2. Cautious correction of severe anemia to avoid fluid overload 3. Consider transfusion before procedures in patients with cardiac compromise 4. Optimize hemoglobin levels in patients with underlying cardiopulmonary disease 5. Monitor for pulmonary hypertension in chronic hemolytic anemias

  28. Q: What is the approach to a child with suspected bone marrow failure syndrome?

    A: Approach to suspected bone marrow failure: 1. Detailed history: family history, consanguinity, prior cytopenias, infections, medications 2. Physical exam: look for dysmorphic features, skin changes, short stature 3. Initial investigations: - Complete blood count with reticulocyte count - Peripheral blood smear - Bone marrow aspiration and biopsy - Cytogenetics 4. Specialized tests: - Chromosomal breakage studies (for Fanconi anemia) - Telomere length analysis (for dyskeratosis congenita) - Genetic testing panels for inherited bone marrow failure syndromes 5. Multidisciplinary management: hematology, genetics, endocrinology, etc. 6. Consider hematopoietic stem cell transplantation for severe cases 7. Family screening and genetic counseling

Tags:

Powered by Blogger.